Skip Navigation


European Heart Journal Advance Access originally published online on April 8, 2005
European Heart Journal 2006 27(6):691-699; doi:10.1093/eurheartj/ehi195
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/6/691    most recent
ehi195v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Christ, M.
Right arrow Articles by Maisch, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christ, M.
Right arrow Articles by Maisch, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy

Michael Christ*, Theresia Klima, Wolfram Grimm, Hans-Helge Mueller and Bernhard Maisch

Klinik für Innere Medizin, Kardiologie und Intensivmedizin, Philipps University Marburg, Baldingerstraße, D-35033 Marburg, Germany

Received 12 August 2004; revised 28 January 2005; accepted 3 February 2005; online publish-ahead-of-print 8 April 2005.

* Corresponding author. Tel: +49 6421 286 6462; fax: +49 6421 953825. E-mail address: Christ_michael{at}yahoo.de

See page 641 for the editorial comment on this article (doi:10.1093/eurheartj/ehi812)

Aims Previous studies indicate that low cholesterol levels are associated with adverse prognosis in heart failure patients, because elevated lipoprotein levels may negate bacterial endotoxin load induced by gastrointestinal congestion.

Methods and results We examined the prognostic significance of lipid levels in a cohort of 422 patients with idiopathic dilated cardiomyopathy (iDCM) [50±12 years, 342 males, 80 females, left ventricular ejection fraction (LV-EF): 31.6±10.6%]. During 42 months of follow-up, 86 patients (20.3%) died or received a heart transplant. In univariate Cox regression analysis, reduced LV-EF, high New York Heart Association (NYHA) class, and increased LV end-diastolic diameter (LVEDD) were strong risk factors associated with that endpoint, whereas decreased total cholesterol, HDL-cholesterol, and apoprotein I levels were identified as weak risk predictors. After step-wise multivariable analysis, only LVEDD, NYHA class, and LV-EF emerged as parameters independently contributing to the model predicting risk for death or heart transplantation (P<0.05). Cholesterol levels were positively associated with LV-EF and negatively associated with LVEDD (P<0.05). Circulating sCD14 levels, a marker of endotoxin exposure, were related to cholesterol levels (P<0.05) and LV-EF (P<0.05).

Conclusion Decreased cholesterol levels do not independently predict adverse prognosis in patients with iDCM. Our findings indicate that low cholesterol levels are dependent on the severity of cardiac disease.

Key Words: Cholesterol • Chronic heart failure • Dilated cardiomyopathy • Risk stratification


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Threats, opportunities, and statins in the modern management of heart failure
John G.F. Cleland, Huan Loh, Jonathan Windram, Kevin Goode, and Andrew L. Clark
EHJ 2006 27: 641-643. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
J. G.F. Cleland, H. Loh, J. Windram, K. Goode, and A. L. Clark
Threats, opportunities, and statins in the modern management of heart failure
Eur. Heart J., March 2, 2006; 27(6): 641 - 643.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.